Helium Health report its Series B fundraising round closed at $30 million to further the telemedicine start-up’s expansion with additional services backed by investors funds for the start-up telemedicine net value that nears half a hundred million dollars.
The start-up e-health company intends to utilize the funds to expand its presence in the African tech space where it prepares to debut its FinTech solutions as it expands its services in general.
Three years ago, Helium Health completed a Series A funding round with ten million dollars and now the Series B round closed at thirty million dollars to promote the in-app Helium Wallet that bankrolls Healthcare financing while the custom e-health services front line the start-up company brand.
Helium Health CEO & co-founder, Adegoke Olubusi said that the $30 million expansion is likely to focus on the platform expansion that is committed to giving patients an edge to sort their medical bills.
“We believe in a future where good healthcare is a reality for all Africans, not just the few. We are deeply committed to supporting both private healthcare providers and public health stakeholders with finance, technology, and data to achieve that vision. We are delighted to have such seasoned healthcare investors accompany us on our journey,” Olubusi said.
Helium Health gives healthcare providers a comprehensive suite of technology solutions dedicated to managing every aspect of healthcare delivery, from electronic medical records and telemedicine to administration and financial management.
The nature of the start-up company has reportedly attracted investors to buy the idea of offering tokens to hike the telemedicine start-up net value to further its growth and innovation in financial inclusion per the company’s network of health records
Helium Health’s Series B round was led by AXA IM Alts with the most offering that geared other investors to offer donations to sum the $30 million including, Capria Ventures, Angaza Capital, 23&Me, Flatworld Partners, Global Ventures, Tencent, Ohara Pharmaceuticals, LCY Group, WTI, and AAIC participated in raising funds for the e-health start-up company.
